Vicente Muedra Navarro-rekin lankidetzan egindako argitalpenak (7)

2018

  1. Dexamethasone preconditioning in cardiac procedures reduces decreased antithrombin activity and is associated to beneficial outcomes: Role of endothelium

    Frontiers in Pharmacology, Vol. 9, Núm. SEP

2017

  1. Changes in the expression of α1B-adrenoceptor in peripheral mononuclear cells correlates with blood pressure and plasmatic homocysteine

    Biomedicine and Pharmacotherapy, Vol. 88, pp. 721-727

2015

  1. Glucocorticoids as modulators of expression and activity of Antithrombin (At): Potential clinical relevance

    Thrombosis Research, Vol. 135, Núm. 1, pp. 183-191

  2. β2-and β1-adrenoceptor expression exhibits a common regulatory pattern with GRK2 and GRK5 in human and animal models of cardiovascular diseases

    Journal of Cardiovascular Pharmacology, Vol. 66, Núm. 5, pp. 478-486

2013

  1. Antithrombin activity and outcomes in patients undergoing cardiac surgery with cardiopulmonary bypass

    Blood Coagulation and Fibrinolysis, Vol. 24, Núm. 4, pp. 454-457

  2. Papel de la antitrombina iii en cirugía cardiaca

    Revista Espanola de Anestesiologia y Reanimacion, Vol. 60, Núm. 9, pp. 519-527

2010

  1. β-Adrenoceptor and GRK3 expression in human lymphocytes is related to blood pressure and urinary albumin excretion

    Journal of Hypertension, Vol. 28, Núm. 6, pp. 1281-1289